Why the study?
Iron homeostasis may significantly impact outcomes in critically ill patients with AF, but its prognostic value remains unclear.
Do iron-metabolism biomarkers predict mortality in critically ill patients with atrial fibrillation?
Do iron-metabolism biomarkers predict mortality in critically ill patients with atrial fibrillation?
Iron-metabolism indicators, particularly TIBC, provide strong prognostic value for risk stratification and predicting 1-year mortality in critically ill patients with atrial fibrillation.
May aid risk stratification in critically ill AF; hypothesis-generating and requires prospective validation.
Iron homeostasis may significantly impact outcomes in critically ill patients with atrial fibrillation (AF), yet its prognostic value remains unclear. Analyzing 2145 AF patients from MIMIC-IV database, we found 43% mortality (n = 928) at 1-year follow-up. Elevated ferritin (Q4 HR 1.59, 95%CI 1.30-1.95, P < 0.001) and serum iron (Q4 HR 1.33, 95%CI 1.11-1.60, P = 0.002) predicted higher mortality, while higher transferrin (Q4: HR 0.65, 95%CI: 0.53-0.79, P < 0.001) and TIBC (Q4: HR 0.64, 95%CI: 0.53-0.79, P < 0.001) were protective. The gradient boosting decision trees model achieved excellent prediction (AUC 0.85 training/validation, 0.71 testing), with TIBC as the top predictor. These iron-metabolism indicators provide strong prognostic value for risk stratification in critically ill patients with AF.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: